Medical Weight Loss for Indio, California Residents
Indio, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Important: Compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical. Eligibility and results vary.
Physician-supervised GLP-1 programs from $166/month, serving Indio through telehealth from our Costa Mesa, California clinic. Doctor review $119. Bilingual support available.
Why Indio Residents Choose New Hope Weight Loss
New Hope was designed around the way Indio residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense fulfillment of your medication is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.
Indio patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
Living in Indio, California means your weight-loss care comes to you online rather than the other way around, with Dr. Anjmun Sharma supervising each step from our Costa Mesa practice. We care for patients throughout downtown Indio and the greater Coachella Valley. From your first question to your ongoing refills, the whole California experience is built to feel personal, private, and genuinely supported.
Consultation timing for Indio patients depends on intake completeness and clinician availability. Please note that our compounded semaglutide and tirzepatide are not FDA-approved and are not brand-identical, and results vary from person to person. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.
GLP-1 Weight Loss Programs Available
Semaglutide (90-Day Metabolic Reset)
For context, STEP 1 reported an average 14.9% at 68 weeks for brand semaglutide. That result does not predict response to compounded semaglutide, which is not FDA-approved or brand-identical. Results vary, and the appropriate option depends on physician review, tolerability, access, and total cost.
Tirzepatide (Dual-Action Program)
For context, SURMOUNT-1 reported an average 20.9% at 72 weeks for brand tirzepatide 15 mg. That result does not predict response to compounded tirzepatide, which is not FDA-approved or brand-identical. Results vary, and the appropriate option depends on physician review, tolerability, access, and total cost.
Physician review is $119. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted.
How Telehealth Works for Indio
Step 1. Complete the online intake and weight-history quiz from your phone or laptop.
Step 2. Dr. Sharma reviews everything and meets you over secure video, after intake review, to confirm whether compounded semaglutide or tirzepatide makes sense for you.
Step 3. If appropriate, medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment.
Step 4. You check in by video for follow-ups, so adjusting your dose never means a drive across California.
Frequently Asked Questions, Indio
Where is the closest New Hope Weight Loss to Indio?
Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Indio, California patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.
Is in-person attendance required for patients from Indio?
It is not. We run a complete telehealth model, so people in Indio handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment.
What should a Indio patient budget for care?
The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Indio patients are not charged any extra distance fee.
What areas of Indio do you serve?
We serve patients from across Indio by telehealth, including downtown Indio and the greater Coachella Valley.
How is medication fulfillment handled?
After Dr. Sharma approves your plan, medication fulfillment is considered only if a prescription is approved and the dispensing pharmacy confirms it can fulfill the prescription for the location where the patient will receive care; the pharmacy confirms packaging and shipping details before fulfillment, packaging confirmed by the dispensing pharmacy for the patient location in Indio, if the dispensing pharmacy confirms fulfillment. The dispensing pharmacy confirms any fulfillment timeline, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Indio, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.